Vaxcyte, Inc. (PCVX) vs Praxis Precision Medicines, Inc. (PRAX)
Vaxcyte, Inc. and Praxis Precision Medicines, Inc. are both Biotechnology companies. Vaxcyte, Inc. and Praxis Precision Medicines, Inc. are of similar size ($8.5B and $7.9B). Across the 10 metrics below, Praxis Precision Medicines, Inc. leads on 6 and Vaxcyte, Inc. on 4.
Valuation
Profitability
| Metric | PCVX | PRAX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (36.51%) | (38.86%) | (57.72%) |
| Return on assets | (33.03%) | (36.80%) | (49.22%) |
| Return on invested capital | (57.30%) | (40.58%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack